Anaplastic lymphoma kinase in human cancer

Antonella Barreca, Elena Lasorsa, Ludovica Riera, Rodolfo Machiorlatti, Roberto Piva, Maurilio Ponzoni, Ivo Kwee, Francesco Bertoni, Pier Paolo Piccaluga, Stefano A. Pileri, Giorgio Inghirami

Research output: Contribution to journalArticle

Abstract

The receptor tyrosine kinases (RTKs) play a critical role, controlling cell proliferation, survival, and differentiation of normal cells. Their pivotal function has been firmly established in the pathogenesis of many cancers as well. The anaplastic lymphoma kinase (ALK), a transmembrane RTK, originally identified in the nucleophosmin (NPM)-ALK chimera of anaplastic large cell lymphoma, has emerged as a novel tumorigenic player in several human cancers. In this review, we describe the expression of the ALK-RTK, its related fusion proteins, and their molecular mechanisms of activation. Novel tailored strategies are briefly illustrated for the treatment of ALK-positive neoplasms.

Original languageEnglish
JournalJournal of Molecular Endocrinology
Volume47
Issue number1
DOIs
Publication statusPublished - Aug 2011

Fingerprint

Receptor Protein-Tyrosine Kinases
Neoplasms
Anaplastic Large-Cell Lymphoma
Protein-Tyrosine Kinases
Cell Differentiation
Cell Survival
Cell Proliferation
anaplastic lymphoma kinase
Proteins
nucleophosmin

ASJC Scopus subject areas

  • Endocrinology
  • Molecular Biology

Cite this

Barreca, A., Lasorsa, E., Riera, L., Machiorlatti, R., Piva, R., Ponzoni, M., ... Inghirami, G. (2011). Anaplastic lymphoma kinase in human cancer. Journal of Molecular Endocrinology, 47(1). https://doi.org/10.1530/JME-11-0004

Anaplastic lymphoma kinase in human cancer. / Barreca, Antonella; Lasorsa, Elena; Riera, Ludovica; Machiorlatti, Rodolfo; Piva, Roberto; Ponzoni, Maurilio; Kwee, Ivo; Bertoni, Francesco; Piccaluga, Pier Paolo; Pileri, Stefano A.; Inghirami, Giorgio.

In: Journal of Molecular Endocrinology, Vol. 47, No. 1, 08.2011.

Research output: Contribution to journalArticle

Barreca, A, Lasorsa, E, Riera, L, Machiorlatti, R, Piva, R, Ponzoni, M, Kwee, I, Bertoni, F, Piccaluga, PP, Pileri, SA & Inghirami, G 2011, 'Anaplastic lymphoma kinase in human cancer', Journal of Molecular Endocrinology, vol. 47, no. 1. https://doi.org/10.1530/JME-11-0004
Barreca, Antonella ; Lasorsa, Elena ; Riera, Ludovica ; Machiorlatti, Rodolfo ; Piva, Roberto ; Ponzoni, Maurilio ; Kwee, Ivo ; Bertoni, Francesco ; Piccaluga, Pier Paolo ; Pileri, Stefano A. ; Inghirami, Giorgio. / Anaplastic lymphoma kinase in human cancer. In: Journal of Molecular Endocrinology. 2011 ; Vol. 47, No. 1.
@article{260a11fe00034330b88d3294ea5b0dca,
title = "Anaplastic lymphoma kinase in human cancer",
abstract = "The receptor tyrosine kinases (RTKs) play a critical role, controlling cell proliferation, survival, and differentiation of normal cells. Their pivotal function has been firmly established in the pathogenesis of many cancers as well. The anaplastic lymphoma kinase (ALK), a transmembrane RTK, originally identified in the nucleophosmin (NPM)-ALK chimera of anaplastic large cell lymphoma, has emerged as a novel tumorigenic player in several human cancers. In this review, we describe the expression of the ALK-RTK, its related fusion proteins, and their molecular mechanisms of activation. Novel tailored strategies are briefly illustrated for the treatment of ALK-positive neoplasms.",
author = "Antonella Barreca and Elena Lasorsa and Ludovica Riera and Rodolfo Machiorlatti and Roberto Piva and Maurilio Ponzoni and Ivo Kwee and Francesco Bertoni and Piccaluga, {Pier Paolo} and Pileri, {Stefano A.} and Giorgio Inghirami",
year = "2011",
month = "8",
doi = "10.1530/JME-11-0004",
language = "English",
volume = "47",
journal = "Journal of Molecular Endocrinology",
issn = "0952-5041",
publisher = "Society for Endocrinology",
number = "1",

}

TY - JOUR

T1 - Anaplastic lymphoma kinase in human cancer

AU - Barreca, Antonella

AU - Lasorsa, Elena

AU - Riera, Ludovica

AU - Machiorlatti, Rodolfo

AU - Piva, Roberto

AU - Ponzoni, Maurilio

AU - Kwee, Ivo

AU - Bertoni, Francesco

AU - Piccaluga, Pier Paolo

AU - Pileri, Stefano A.

AU - Inghirami, Giorgio

PY - 2011/8

Y1 - 2011/8

N2 - The receptor tyrosine kinases (RTKs) play a critical role, controlling cell proliferation, survival, and differentiation of normal cells. Their pivotal function has been firmly established in the pathogenesis of many cancers as well. The anaplastic lymphoma kinase (ALK), a transmembrane RTK, originally identified in the nucleophosmin (NPM)-ALK chimera of anaplastic large cell lymphoma, has emerged as a novel tumorigenic player in several human cancers. In this review, we describe the expression of the ALK-RTK, its related fusion proteins, and their molecular mechanisms of activation. Novel tailored strategies are briefly illustrated for the treatment of ALK-positive neoplasms.

AB - The receptor tyrosine kinases (RTKs) play a critical role, controlling cell proliferation, survival, and differentiation of normal cells. Their pivotal function has been firmly established in the pathogenesis of many cancers as well. The anaplastic lymphoma kinase (ALK), a transmembrane RTK, originally identified in the nucleophosmin (NPM)-ALK chimera of anaplastic large cell lymphoma, has emerged as a novel tumorigenic player in several human cancers. In this review, we describe the expression of the ALK-RTK, its related fusion proteins, and their molecular mechanisms of activation. Novel tailored strategies are briefly illustrated for the treatment of ALK-positive neoplasms.

UR - http://www.scopus.com/inward/record.url?scp=79961088497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79961088497&partnerID=8YFLogxK

U2 - 10.1530/JME-11-0004

DO - 10.1530/JME-11-0004

M3 - Article

C2 - 21502284

AN - SCOPUS:79961088497

VL - 47

JO - Journal of Molecular Endocrinology

JF - Journal of Molecular Endocrinology

SN - 0952-5041

IS - 1

ER -